Pseudomonas aeruginosa (2018 Data)
Antibiotic |
% Susceptible |
Antibiotic |
% Susceptible |
|
Ampicillin | - |
Imipenem | 91 |
|
Azithromycin | - |
Levofloxacin | 89 |
|
Aztreonam | 86 |
Meropenem | 98 |
|
Cefazolin | - |
Moxifloxacin | +
|
|
Cefepime | 95 |
Nitrofurantoin | -
|
|
Ceftazidime | 96 |
Oxacillin/Naf | - |
|
Ceftriaxone | - |
Penicillin | - |
|
Cefuroxime | - |
Piperacillin | +
|
|
Ciprofloxacin | 90 |
Piperacillin/tazo | 99 |
|
Clarithromycin | - |
Ticarcillin/Clav | + |
|
Clindamycin | - |
Tobramycin | 99 |
|
Doxycycline | - |
TMP/SMX | - |
|
Erythromycin | - |
Unasyn/Aug | - |
|
Gentamicin | 90 |
Vancomycin | - |
|
Number of isolates tested: 494
Comments:
For historical susceptibility data click here
Numeric data represent local susceptibility data.
(+) = usually effective or >60% susceptible; (+/-) = clinical trials lacking or 30-60% susceptible; (-) = not effective clinically or <30% susceptible - Adapted with permission from The Sanford Guide to Antimicrobial Therapy
(*) Local (non-Sanford Guide) opinion
(S) = synergistic with penicillin/ampicillin;
(&) nitrofurantoin only useful for lower tract urinary tract infections
(+) = usually effective or >60% susceptible; (+/-) = clinical trials lacking or 30-60% susceptible; (-) = not effective clinically or <30% susceptible - Adapted with permission from The Sanford Guide to Antimicrobial Therapy
(*) Local (non-Sanford Guide) opinion
(S) = synergistic with penicillin/ampicillin;
(&) nitrofurantoin only useful for lower tract urinary tract infections